Madrigal Pharmaceuticals Statistics
NASDAQ: MDGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
487.72-8.73 (-1.76%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Madrigal Pharmaceuticals by the numbers
Madrigal Pharmaceuticals has a market capitalization of $11.27 billion based on 23.10M shares outstanding. With trailing EPS of $-12.62, Madrigal Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.4% below its 50-day average and 4.4% below its 200-day average.
Average daily trading volume is 289.84K shares, or about $141.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MDGL valuation vs. peer median
| Metric | MDGL | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.27B | $10.45B | +8% |
| Forward P/E | 50.7 | 19.0 | +166% |
| Avg. volume | 289.84K | 1.96M | -85% |
Peer median across 8 companies: ELAN, BMRN, RDY, CORT, BBIO, PTGX, AXSM, ARWR.
Valuation
- Market cap
- $11.27B
- Forward P/E
- 50.67
- Price / sales (latest FY)
- 11.76
- EPS (TTM)
- $-12.62
- Shares outstanding
- 23.10M
Price and trading
- Previous close
- 496.45
- Open
- 492.61
- Day range
- 486.77 – 502.34
- 52-week range
- 393.61 – 615.00
- 52-week change
- +11.79%
- 50-day moving average
- 521.14
- 200-day moving average
- 510.06
- Beta
- —
- Volume
- 256.24K
- Average volume
- 289.84K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 11.27B
- Forward Pe
- 50.67
- Eps
- -12.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 615.00
- Week52 Low
- 393.61
- Avg Volume
- 289.84K
- Shares Outstanding
- 23.10M
- Ma50
- 521.14
- Ma200
- 510.06
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -20.70%
- Pct From52w Low
- 23.91%